Muscarinic Acetylcholine Receptor M2 Antikörper

Produktnummer ABIN7880412

Der Maus Monoklonal anti-Muscarinic Acetylcholine Receptor M2 Antikörper wird verwendet zum Nachweis von Muscarinic Acetylcholine Receptor M2 in Proben von Human und Maus. Er wurde validiert für WB, IF, IHC (p) und FACS.

Kurzübersicht für Muscarinic Acetylcholine Receptor M2 Antikörper (ABIN7880412)

Target: Muscarinic Acetylcholine Receptor M2 (CHRM2) (Cholinergic Receptor, Muscarinic 2 (CHRM2))

Reaktivität: Human, Maus

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Muscarinic Acetylcholine Receptor M2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Klon: 1424CT461-78-60

Produktdetails anti-Muscarinic Acetylcholine Receptor M2 Antikörper

Verwendungszweck: CHRM2 Antibody

Aufreinigung: Protein G affinity

Immunogen: A recombinant human protein was used as the immunogen for the CHRM2 antibody.

Isotyp: IgG1, kappa

Anwendungsinformationen

Applikationshinweise: The stated application concentrations are suggested starting points. Titration of the CHRM2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the CHRM2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Details zu Muscarinic Acetylcholine Receptor M2

Target: Muscarinic Acetylcholine Receptor M2 (CHRM2) (Cholinergic Receptor, Muscarinic 2 (CHRM2))

Andere Bezeichnung: CHRM2

Hintergrund: The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is adenylate cyclase inhibition.

UniProt: P08172